Anti-inflammatory properties of unfractioned heparin in patients with highly active ulcerative colitis: a pilot study.
Folwaczny
C
C
Fricke
H
H
Endres
S
S
Hartmann
G
G
Jochum
M
M
Loeschke
K
K
D000328:Adult; D000925:Anticoagulants / Q000627:therapeutic use*; D001798:Blood Proteins / Q000378:metabolism; D002097:C-Reactive Protein / Q000378:metabolism; D002352:Carrier Proteins / Q000378:metabolism; D003093:Colitis, Ulcerative / Q000188:drug therapy* / Q000276:immunology*; D004797:Enzyme-Linked Immunosorbent Assay; D005260:Female; D006493:Heparin / Q000627:therapeutic use*; D006801:Humans; D019041:L-Selectin / Q000097:blood; D008297:Male; D010865:Pilot Projects; D016896:Treatment Outcome; D014409:Tumor Necrosis Factor-alpha / Q000378:metabolism
D000925:Anticoagulants; D001798:Blood Proteins; D002352:Carrier Proteins; D014409:Tumor Necrosis Factor-alpha; D019041:L-Selectin; D006493:Heparin; D002097:C-Reactive Protein